Enhancing outcomes in pediatric populations with continuous renal replacement therapy: Current multidisciplinary strategies and innovations

Flora R. Gallegos , Parth Shirode , Max Gilliland , Jieji Hu , Amanda Osagie-Ogbeide , Sidharth Kumar Sethi , Rupesh Raina
{"title":"Enhancing outcomes in pediatric populations with continuous renal replacement therapy: Current multidisciplinary strategies and innovations","authors":"Flora R. Gallegos ,&nbsp;Parth Shirode ,&nbsp;Max Gilliland ,&nbsp;Jieji Hu ,&nbsp;Amanda Osagie-Ogbeide ,&nbsp;Sidharth Kumar Sethi ,&nbsp;Rupesh Raina","doi":"10.1016/j.jointm.2025.03.005","DOIUrl":null,"url":null,"abstract":"<div><div>Continuous renal replacement therapy (CRRT) is critical in managing several conditions in critically ill pediatric patients. The clinical and economic impact of CRRT is profound and diverse, similar to the patients and conditions it is used to treat. Although much medical literature surrounds CRRT in adults, there remains a gap in research for pediatric populations. This article provides a brief review of current kidney replacement therapies, focusing on CRRT indications, prescribing practices, and modality comparisons. We aim to evaluate the current practical considerations and effectiveness of these therapies and highlight recent advances and future directions, especially in relation to the pediatric patient population. We analyzed recent literature and clinical guidelines on CRRT for critically ill pediatric patients. Key considerations include prescription strategies and comparison of different CRRT modalities, and essential considerations include anticoagulation, settings, and complications. We also explore recent advances in CRRT technologies and their role in clinical management. CRRT offers significant benefits for patients with severe kidney impairments by providing continuous support and improving outcomes. Discussing current recommendations and uses of CRRT and recent advancements will improve its safety and efficacy. Advances in technology and clinical practice are enhancing the use of CRRT, though further research is needed to optimize treatment and address ongoing challenges.</div></div>","PeriodicalId":73799,"journal":{"name":"Journal of intensive medicine","volume":"5 4","pages":"Pages 323-332"},"PeriodicalIF":0.0000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of intensive medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667100X25000271","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Continuous renal replacement therapy (CRRT) is critical in managing several conditions in critically ill pediatric patients. The clinical and economic impact of CRRT is profound and diverse, similar to the patients and conditions it is used to treat. Although much medical literature surrounds CRRT in adults, there remains a gap in research for pediatric populations. This article provides a brief review of current kidney replacement therapies, focusing on CRRT indications, prescribing practices, and modality comparisons. We aim to evaluate the current practical considerations and effectiveness of these therapies and highlight recent advances and future directions, especially in relation to the pediatric patient population. We analyzed recent literature and clinical guidelines on CRRT for critically ill pediatric patients. Key considerations include prescription strategies and comparison of different CRRT modalities, and essential considerations include anticoagulation, settings, and complications. We also explore recent advances in CRRT technologies and their role in clinical management. CRRT offers significant benefits for patients with severe kidney impairments by providing continuous support and improving outcomes. Discussing current recommendations and uses of CRRT and recent advancements will improve its safety and efficacy. Advances in technology and clinical practice are enhancing the use of CRRT, though further research is needed to optimize treatment and address ongoing challenges.
持续肾替代治疗提高儿科人群的预后:当前多学科策略和创新
持续肾替代治疗(CRRT)是处理危重儿科患者几种情况的关键。CRRT的临床和经济影响是深刻而多样的,与它用于治疗的患者和疾病相似。尽管很多医学文献都围绕着CRRT在成人中的应用,但对儿科人群的研究仍然存在空白。本文简要回顾了目前的肾脏替代疗法,重点是CRRT的适应症、处方实践和模式比较。我们的目的是评估这些疗法目前的实际考虑和有效性,并强调最近的进展和未来的方向,特别是在儿科患者群体中。我们分析了最近关于儿科危重患者CRRT的文献和临床指南。主要考虑因素包括处方策略和不同CRRT方式的比较,基本考虑因素包括抗凝、设置和并发症。我们还探讨了CRRT技术的最新进展及其在临床管理中的作用。CRRT通过提供持续的支持和改善预后,为严重肾损害患者提供了显著的益处。讨论CRRT目前的建议和使用以及最近的进展将提高其安全性和有效性。技术和临床实践的进步正在加强CRRT的使用,尽管需要进一步的研究来优化治疗和应对持续的挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of intensive medicine
Journal of intensive medicine Critical Care and Intensive Care Medicine
CiteScore
1.90
自引率
0.00%
发文量
0
审稿时长
58 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信